Picture of Stablecoin Development logo

SDEV Stablecoin Development News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapValue Trap

Brief: Novabay Pharmaceuticals Reports 2022 Fourth Quarter And Full Year Financial Results

March 30 (Reuters) - NovaBay Pharmaceuticals Inc
 NBY.A :
    * NOVABAY PHARMACEUTICALS REPORTS 2022 FOURTH QUARTER AND
FULL
YEAR FINANCIAL RESULTS
    * NOVABAY PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $4.33

Source text for Eikon:  ID:nBw74kRDDa 
Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Stablecoin Development

See all news